Bill Gates bets $10M on the future of drug development software

It may amount to only spare change for Bill Gates, but the billionaire's $10 million investment in a Portland-based drug development software outfit could give him a strategic position in the quest to use powerful computers and state-of-the-art software to reengineer the development of pharmaceuticals. Gates told the Wall Street Journal that he has sunk his money into Schrodinger, a company with a staff of 140 and a mission to create software that can be used to simulate the lab work that...